OCX stock forecast
Our latest prediction for OncoCyte Corp.'s stock price was made on the Sept. 12, 2019 when the stock price was at 1.95$.
In the short term (2weeks), OCX's stock price should outperform the market by 4.18%. During that period the price should oscillate between -11.05% and +19.91%.
In the medium term (3months), OCX's stock price should outperform the market by 8.12%. During that period the price should oscillate between -23.98% and +47.74%.Get email alerts
About OncoCyte Corp.
OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.41$ per share.
The book value per share is 0.17$
Three months stock forecastSept. 12, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|